Medtronic

Loading

Overview

The Medtronic Newsroom is designed to assist media in finding news and information about our company.

Medtronic, founded in a Minneapolis garage in 1949 by Earl Bakken and his brother-in-law, Palmer Hermundslie, is the world’s leading maker of medical devices.

Our Mission has not changed since Earl Bakken wrote it in 1960: To contribute to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health and extend life.

More than 9 million lives are enhanced every year by a Medtronic product or therapy; that’s one every three seconds.

Medtronic is headquartered in Minneapolis, MN and operates in more than 140 countries. The company employs 46,000 people, including 5,800 scientists and engineers, pursuing research and innovation that has led to more than 28,000 patents.

Most Recent Press ReleasesRead More
DateTitle
04/22/14Medtronic Announces First U.S. Implant of Implantable Cardioverter-Defibrillator System Designed to Allow Full-Body MRI Scans
First Patient Enrolled in U.S. Pivotal Clinical Trial to Evaluate the Evera MRI(TM) ICD System MINNEAPOLIS - April 22, 2014 -Medtronic today announced the first U.S. implant of the Evera MRI(TM) SureScan® implantable cardioverter-defibrillator (ICD) System, following U.S. Food and Drug Administration (FDA) approval for its Investigational Device Exemption (IDE) application and pivotal clinical trial protocol. Evera MRI is the first ICD system to be evaluated in the U.S. that allows for magnetic... 
04/21/14Federal Appeals Court Agrees to Medtronic Request to Postpone Injunction
MINNEAPOLIS - April 21, 2014 - The Federal Circuit Court of Appeals today granted a request from Medtronic, Inc. (NYSE: MDT) to postpone the implementation of an  injunction that would have prevented the company from selling its CoreValve® System in the United States. This means the injunction will only take effect if the appellate court determines the injunction was properly issued. In addition, last week the Court of Appeals agreed to an expedited appeal of the injunction ruling, with the las... 
04/21/14Update on CoreValve Federal District Court Ruling; Court Agrees to Expedited Appeal
MINNEAPOLIS - April 21, 2014 - Medtronic, Inc. (NYSE: MDT) today issued an updated statement on the recent ruling by Federal District Court of Delaware. The ruling granted in part Edwards Lifesciences' motion for a preliminary injunction that prevents Medtronic from selling or offering to sell its CoreValve® System in the United States, except through a mechanism that Medtronic is pursuing with Edwards Lifesciences that would allow currently trained sites to treat patients with CoreValve based o... 
Medtronic in the News
DateTitle
02/18/14Innovation is Just What the Doctor Ordered - Shanghai Daily
08/20/13Medtronic Plans Expansion to Health Services, CEO Says – Bloomberg
08/11/13Medtronic Expands into Disease Management – Wall Street Journal
Receive E-mail Alerts E-mail Alert Icon
Sign up to receive e-mail alerts whenever Medtronic posts new information to the site. Just enter your e-mail address and click Submit.
 


Section Navigation

Spotlight

Medtronic featured in 2014 Business Roundtable Sustainability Report. Learn More.

Contact Us

Medtronic
Medtronic, Inc.
main number(763) 514-4000
Medtronic
Public Relations
710 Medtronic Pkwy NE LC-110
Minneapolis, MN  55432

Media Contacts

Latest Tweets

Medtronic News
@Medtronic

Latest Tweets

Omar Ishrak
@MedtronicCEO